33 results
8-K
ONCR
Oncorus, Inc.
5 Aug 22
Regulation FD Disclosure
7:10am
(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure.
Oncorus, Inc. (the “Company”) from time to time presents and/or distributes to the investment community
424B5
ONCR
Oncorus, Inc.
19 Nov 21
Prospectus supplement for primary offering
4:41pm
treatment centers, third-party payors and others in the medical community necessary for commercial success. The revenues that we generate from
S-3
yrx8q2ou004cf2b3gzyu
3 Nov 21
Shelf registration
5:00pm
10-K
pyurgnboqhbxo0e
10 Mar 21
Annual report
4:12pm
424B4
wyoujn81z
12 Feb 21
Prospectus supplement with pricing info
4:23pm
DRS
EX-10.12
48cn18 a1m
28 Jan 21
Draft registration statement
12:00am
DRS
mkkpyxk5g2nyy
28 Jan 21
Draft registration statement
12:00am
8-K
EX-99.1
lm6t eqw6qw
7 Dec 20
Oncorus Appoints Steve Harbin as Chief Operating Officer and Chief of Staff
9:17am
10-Q
9bj qfyiav
12 Nov 20
Quarterly report
8:01am
424B4
hau527ut5ir
2 Oct 20
Prospectus supplement with pricing info
12:00am